Перевести на Переведено сервисом «Яндекс.Перевод»

Raptor Pharmaceuticals

Country
USA
Краткое название
Raptor Pharmaceuticals
Headquarters
9 Commercial Boulevard Suite 200
Members of the board

Christopher M. Starr, Ph.D.,
CEO and Co-founder
Julie Anne Smith,
Executive Vice President, Strategy and Chief Operating Officer
Thomas E. "Ted" Daley,
Chief Business Officer
Georgia Erbez,
Chief Financial Officer
Henk Doude van Troostwij,
General Manager, European Commercial Operations
Eric B. Mosbrooker,
Vice President, Health Services
Kathy L. Powell,
Chief Quality Officer
Patrick Reichenberger,
Vice President, Commercial Operations
Patrice P. Rioux, M.D., Ph.D,
Chief Medical Officer
Kim R. Tsuchimoto,
Vice President, Finance
Todd C. Zankel, Ph.D.,
Chief Scientific Officer and Co-founder

Categories medicine
Neurology, Oncology
Stage of the project
Production
Disease
Intestine cancer, Multiocular sclerosis
Ticker
RPTP
Current owners

Raymond W. ("Bill") Anderson,
Suzanne L. Bruhn, Ph.D.,
Richard L. Franklin, M.D., Ph.D.,
Llew Keltner, M.D., Ph.D.,
Erich Sager,
Vijay B. Samant,
Christopher M. Starr, Ph.D.,
Timothy P. Walbert

Assets
1.2500
Technology
Cell Technologies, Pharmaceuticals, Chemistry